Image 1_Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variants.tiff

<p>The design focus of the first-generation COVID-19 vaccines was on the use of the SARS-CoV-2 spike (S) protein as the primary vaccine immunogen to induce high levels of neutralizing antibodies. Efficacy was repeatedly disrupted due to the diminished neutralizing capacity of vaccine-induced a...

Full description

Saved in:

Bibliographic Details
Main Author:	Amany Elsharkawy (18285577) (author)
Other Authors:	Shannon Stone (19779228) (author), Anchala Guglani (19779231) (author), Felix Wussow (256275) (author), JD Burleson (22599632) (author), Mary Hauser (22599635) (author), Arban Domi (4506175) (author), Pratima Kumari (13249669) (author), Todd R. Albrecht (22599638) (author), Chinonye Dim (19779237) (author), Mark Newman (805798) (author), Don J. Diamond (7354430) (author), Sreenivasa Rao Oruganti (22599641) (author), Mukesh Kumar (132604) (author)
Published:	2025
Subjects:	Genetic Immunology COVID-19 vaccine SARS-CoV-2 K18-hACE-2 B.1 XBB.1.5 T-cells
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Image 1_Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variants.tiff

Similar Items